Informações:
Falhas:
ID
21162
Descrição
An Open-label, One-arm, Study to Evaluate the Hemodynamic Changes and Safety of Nesiritide for Acute Decompensated Heart Failure; ODM derived from: https://clinicaltrials.gov/show/NCT00813202
Link
https://clinicaltrials.gov/show/NCT00813202
Palavras-chave
Versões (1)
- 12/04/2017 12/04/2017 -
Transferido a
12 de abril de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Heart Decompensation NCT00813202
Eligibility Heart Decompensation NCT00813202
- StudyEvent: Eligibility
Similar models
Eligibility Heart Decompensation NCT00813202
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Systolic blood pressure
Item
systolic blood pressure> 90 mmhg
boolean
C0871470 (UMLS CUI [1])
Dyspnea
Item
the subjects must present with dyspnoea at resting state or with minimum activity amount (such as standing up)
boolean
C0013404 (UMLS CUI [1])
Onset of acute decompensate heart failure
Item
onset at this time was complicated with symptoms of acute decompensate heart failure, and it was serious enough to call for hospitalization and treatment with intravenous drug administration
boolean
C1399214 (UMLS CUI [1,1])
C0574845 (UMLS CUI [1,2])
C0574845 (UMLS CUI [1,2])
Reason for decompensation
Item
acute decompensate heart failure was caused by cardiogenic factors rather than pulmonary factors (for example, it was neither cor pulmonale nor chronic heart failure complicated with pneumonia)
boolean
C1399214 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,2])
Count of manifestation
Item
the patients must have at least two of manifestations that related with this acute onset.
boolean
C1280464 (UMLS CUI [1,1])
C0750480 (UMLS CUI [1,2])
C0750480 (UMLS CUI [1,2])
Systolic blood pressure
Item
patients with systolic blood pressure =90 mmhg
boolean
C0871470 (UMLS CUI [1])
Intravenous vasoactive drugs
Item
patients who had been administered with intravenous nitroglycerin or other intravenous vasoactive drugs within 2 hour before administration of the investigational drug
boolean
C0597639 (UMLS CUI [1,1])
C1522726 (UMLS CUI [1,2])
C1522726 (UMLS CUI [1,2])
Acute coronary syndrome
Item
patients who had known or suspected acute coronary syndrome (myocardial infarction with or without increased st segment, or unstable myocardial infarction) within 2 weeks before administration of the investigational drug
boolean
C0948089 (UMLS CUI [1])
Cardiac shock, uncorrected hypovolemia, sodium depletion
Item
patients with cardiac shock or clinical manifestation of uncorrected hypovolemia or sodium depletion (such as clinical signs of excessive diuresis or dehydration), or clinical manifestation induced by other forbidden venous vasoactive agents
boolean
C0036980 (UMLS CUI [1])
C0546884 (UMLS CUI [2])
C0020625 (UMLS CUI [3])
C0546884 (UMLS CUI [2])
C0020625 (UMLS CUI [3])
Severe medical condition
Item
patients with such extremely emergent and unstable clinical conditions that not tolerant to swan-ganz catheter or temporal baseline evaluation
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
Cardiac comorbiditiy
Item
patients with obvious cardiac valvular stenosis (subjects treated by valve-replacement can be included), hypertrophic, restrictive, or obstructive myocardial disease, primary pulmonary hypertension, or complex congenital heart disease.
boolean
C0018787 (UMLS CUI [1,1])
C0009488 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,2])